SCHEMBL27451640

SCHEMBL27451640

O=C(CCN1C(=O)CCC1=O)Nc1ccc(-c2nc3ccccc3s2)cn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.58
▸ RAB9A P51151 8/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ MAPT P10636 3/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ PSMD14 O00487 1/20 0.56
▸ SMN1; SMN2 Q16637 5/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ HPGD P15428 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ ADRB2 P07550 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ MGLL Q99685 10/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ PKM P14618 2/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ NFKB1 P19838 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27451116 0.86 RAB9A (0.77) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27451505 0.81 NPC1 (0.59) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL31050189 0.81 NPC1 (0.59) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL31050188 0.81 NPC1 (0.59) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27451123 0.80 RAB9A (0.68) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27852729 0.80 RAB9A (0.52) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27452146 0.77 NPC1 (0.55) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27451276 0.77 RAB9A (0.54) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27452585 0.75 RAB9A (0.58) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL27451351 0.74 RAB9A (0.68) NPC1RAB9AKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145662-A1 2-SUBSTITUTED THIAZOLE AND BENZOTHIAZOLE COMPOSITIONS AND METHODS AS DUX4 INHIBITORS ALTAY THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback